Functional role of microRNA in acute myeloid leukemia stem cells and their normal

microRNA在急性髓系白血病干细胞及其正常状态中的功能作用

• 批准号: 7666098
• 负责人: CHRISTOPHER Y PARK
• 金额: $ 13.75万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-08-03 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7666098
• 关键词: Accounting; Acute Myelocytic Leukemia; Adult; Anatomy; Antibody Therapy; Apoptosis; Biological Assay; Blast Cell; Bone Marrow Transplantation; Cancer Biology; Cell physiology; Cell surface; Cells; Chromosomal translocation; Chronic Myeloid Leukemia; Chronic Phase; Clinical; Commit; Communities; Comprehensive Cancer Center; Crowding; Culture Techniques; Data; Daughter; Development; Development Plans; Developmental Process; Diagnosis; Diagnostic; Disease; Engraftment; Environment; Epigenetic Process; Event; Exhibits; Experimental Pathology; Fellowship; Figs - dietary; Future; Gene Fusion; Gene Mutation; Gene Targeting; Genes; Genetic; Genome Stability; Goals; Hematopathology; Hematopoiesis; Hematopoietic; Hematopoietic stem cells; Housing; Human; Human Development; Immune; Immunology; Immunophenotyping; In Vitro; Institutes; Investigation; Laboratories; Lead; Lesion; Libraries; Malignant Neoplasms; Malignant lymphoid neoplasm; Methylcellulose; MicroRNAs; Modeling; Molecular; Molecular Profiling; Molecular Target; Mus; Myeloid Leukemia; Oncogenes; Pathogenesis; Pathology; Pathway interactions; Patients; Pediatric Hematology/Oncology; Pharmaceutical Preparations; Phenotype; Play; Population; Principal Investigator; Proliferating; Property; Proteins; Proto-Oncogenes; Regenerative Medicine; Research; Research Personnel; Residencies; Resources; Retroviridae; Role; Sampling; Staging; Stem cells; System; Techniques; Testing; Therapeutic; Time; Tissues; Tort; Training; Transplantation; Triage; Tumor Suppressor Genes; Tumor Suppressor Proteins; Universities; Work; Xenograft Model; Xenograft procedure; base; c-myc Genes; cancer stem cell; carcinogenesis; career; daughter cell; design; effective therapy; granulocyte; improved; in vitro Assay; in vivo; innovation; insight; knock-down; leukemia; leukemic stem cell; leukemogenesis; macrophage; member; mouse model; novel; overexpression; progenitor; prognostic; programs; research study; self-renewal; skills; stem; stem cell biology; stem cell population; tool; tumor

DESCRIPTION (provided by applicant): This 5 year-proposal describes a comprehensive plan for the development of a career in experimental pathology. The principal investigator completed anatomic pathology residency and hematopathology fellowship training at Stanford University and has spent the past two years honing his skills as a diagnostic hematopathologist while spending the majority of his time developing the technical and intellectual skills that will allow him to become an independent investigator. The proposed work will take place in the laboratory of Irving L. Weissman, an internationally recognized leader in the field of stem cell biology, cancer stem cell biology, and hematopoiesis. Given the breadth and depth of intellectual and technological resources, Dr. Weissman's lab represents a unique environment, geared not only to allowing highly creative and innovative projects to come to fruition, but also to train future independent investigators. Given the growing evidence that microRNAs play a role in the development of human cancers, this proposal represents a timely investigation into the pathogenesis of human acute myeloid leukemia (AML). Unlike conventional cancer biology research, the proposed studies will focus on the tumor-initiating, or stem cells, of AML. Because of the unique properties of leukemia stem cells (LSC), including the capacity to initiate tumors, self-renew, and recapitulate disease in xenograft models, it is imperative that we understand the molecular basis of the AML LSC biologic properties. Because of the unique experimental challenges associated with working with primary human samples, a great deal of time has been, and will continue to be, invested in developing improved models to study the role of microRNAs in human AML. The Stanford Institute for Stem Cell Biology and Regenerative Medicine is an ideal setting for these studies. In addition to housing a community of cancer and stem cell biologists, there are numerous opportunities to collaborate with members of other departments through interdisciplinary programs including the Stanford Comprehensive Cancer Center, Immunology Program, and many others. Given the strength of Stanford's clinical divisions (adult and pediatric hematology/oncology, bone marrow transplant, hematopathology), there is significant tissue access as well as opportunities to work with clinical colleagues.

描述（由申请人提供）：这5年的建议描述了一个全面的计划，为职业发展的实验病理学。主要研究者在斯坦福大学完成了解剖病理学住院医师和血液病理学奖学金培训，并在过去两年中磨练了他作为诊断血液病理学家的技能，同时花费了大部分时间来发展技术和智力技能，使他成为一名独立的研究者。 拟定工作将在欧文L.的实验室进行。韦斯曼，国际公认的干细胞生物学，癌症干细胞生物学和造血领域的领导者。鉴于知识和技术资源的广度和深度，Weissman博士的实验室代表了一个独特的环境，不仅可以让高度创造性和创新性的项目取得成果，而且还可以培养未来的独立研究人员。 鉴于越来越多的证据表明microRNA在人类癌症的发展中发挥作用，该提案代表了对人类急性髓细胞白血病（AML）发病机制的及时调查。与传统的癌症生物学研究不同，拟议的研究将集中在AML的肿瘤启动或干细胞上。由于白血病干细胞（LSC）的独特性质，包括在异种移植模型中引发肿瘤、自我更新和重现疾病的能力，我们必须了解AML LSC生物学特性的分子基础。由于与使用原始人类样本相关的独特实验挑战，已经并将继续投入大量时间来开发改进的模型以研究microRNA在人类AML中的作用。 斯坦福大学干细胞生物学和再生医学研究所是这些研究的理想场所。除了容纳癌症和干细胞生物学家的社区，还有许多机会通过跨学科计划，包括斯坦福大学综合癌症中心，免疫学计划，和许多其他部门的成员合作。鉴于斯坦福大学的临床部门（成人和儿科血液学/肿瘤学，骨髓移植，血液病理学）的实力，有显着的组织访问以及与临床同事合作的机会。